Cargando…
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
SIMPLE SUMMARY: Many clinical trials have investigated the role of Immune Checkpoint Inhibitors (ICIs) in pleural mesothelioma (PM), with contrasting results. We performed a systematic review and meta-analysis of clinical trials testing single-agent ICIs or combined treatments in PM patients. Combin...
Autores principales: | Gemelli, Maria, Cortinovis, Diego Luigi, Baggi, Alice, di Mauro, Pierluigi, Calza, Stefano, Berruti, Alfredo, Grisanti, Salvatore, Rota, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775536/ https://www.ncbi.nlm.nih.gov/pubmed/36551550 http://dx.doi.org/10.3390/cancers14246063 |
Ejemplares similares
-
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
por: Borgeaud, Maxime, et al.
Publicado: (2023) -
Sneaky Diagnosis of Pleural Malignant Mesothelioma in Thoracic Surgery: All That Glitters Is Not Gold
por: Orlandi, Riccardo, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
por: Kim, Roger Y., et al.
Publicado: (2021) -
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
por: Vita, Emanuele, et al.
Publicado: (2021) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)